Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a gentle electric zap at key points make emergency gut exams easier for liver patients?

NCT ID NCT07106658

Symptom relief Sponsor: Beijing 302 Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a mild electrical stimulation at specific acupoints (TEAS) helps people with cirrhosis tolerate an urgent endoscopy for suspected variceal bleeding. 180 patients were split into three groups: active TEAS, sham TEAS (electrodes but no current), or standard endoscopy alone. The goal was to see if TEAS improves procedural success and reduces discomfort.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transcutaneous electrical acupoint stimulation (TEAS) using a Hwato SDZ-III device
What this could lead to
If it works, this could offer a simple, drug-free way to make urgent endoscopy more comfortable and successful for people with cirrhosis.
What could go wrong
This is a small, completed trial with 180 participants. The sham group may also show benefit, and results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

180 people

The number who actually took part.

Started

Jul 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

1\. Inclusion Criteria: 1. Patients aged 18-80 years with suspected or confirmed esophagogastric variceal bleeding 2. Confirmed cirrhosis (any etiology/Child-Pugh class) 3. Scheduled for urgent endoscopy as soon as possible following hemodynamic stabilization 4. Ability to provide written informed consent (directly or through legally authorized representative) 2\. Exclusion Criteria: 1. Hepatic encephalopathy ≥ Grade II 2. Cognitive impairment or severe anxiety disorders preventing valid assessment 3. Hemodynamic instability post-resuscitation (systolic BP \<90 mmHg) 4. Skin lesions at acupoint sites 5. Presence of electrical implants (e.g., pacemakers) 6. Allergies to TEAS electrodes or emergency medications 7. Pregnancy or lactation 8. History of long-term opioid use (\>3 months) 9. Inability to provide informed consent 10. Prior TEAS or acupuncture experience (to maintain blinding integrity) 11. Participation in another interventional trial within 30 days 3\. Dropout Criteria: 1. Severe adverse events requiring immediate termination (anaphylaxis, hemodynamic collapse, oxygen desaturation \<85%) 2. Life-threatening complications during endoscopy (esophageal perforation, cardiac arrest) 3. Inability to complete full esophagogastroduodenoscopy due to patient intolerance or technical failure 4. Voluntary withdrawal by participant or legal representative

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cirrhosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cirrhosis of liver esophageal varices with bleeding Fibrosis Gastrointestinal Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cirrhosis Gastrointestinal endoscopy Upper gastrointestinal hemorrhage Variceal bleeding

Contacts and locations

Locations

  • The Fifth Medical Center of PLA General Hospital

    Beijing, Beijing Municipality, 100039, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.